Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “immunotherapy”

175 pharma patents match "immunotherapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 175
Index total 30,257
Page 1 / 8

Quick answer

This filtered view shows 175 pharmaceutical patents matching "immunotherapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

175 results for “immunotherapy” · 30,257 patents in full index Clear search

  1. US 12414983

    CD200AR ligands for cancer immunotherapy

    Regents of the University of Minnesota · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12384830

    Compositions and methods for improving immunotherapy

    Regents of the University of Minnesota · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  3. US 12350322

    Peptide immunogens targeting interleukin 6 (IL-6) and formulations thereof for immunotherapy of diseases impacted by IL-6 dysregulation

    United Biomedical, Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  4. US 12338459

    DNA-chimeric antigen receptor T cells for immunotherapy

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  5. US 12329816

    Immunotherapy with metabolic enzyme expression

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  6. US 12325854

    Crispr-CPF1-related methods, compositions and components for cancer immunotherapy

    Editas Medicine, Inc. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  7. US 12311030

    Antibody-sting agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  8. US 12303551

    Cellular immunotherapy compositions and uses thereof

    Cero Therapeutics Holdings, Inc. · Granted May 20, 2025 · Expires May 15, 2045

    granted
  9. US 12297509

    Biomarkers for predicting tumor response to and toxicity of immunotherapy

    MIRA DX, INC. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  10. US 12280140

    Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  11. US 12275955

    Combining iPSC derived effector cell types for immunotherapy use

    Fate Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  12. US 12233103

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  13. US 12230379

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  14. US 12230378

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  15. US 12230364

    Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  16. US 12226434

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  17. US 12228582

    Method and apparatus for testing near infrared-photoimmunotherapy treatment

    The United States of America as Represented By The Secretary of the Department of Health and Human · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  18. US 12194061

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  19. US 12186428

    Combination taxoid nanoemulsion with immunotherapy in cancer

    Northwestern University · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  20. US 12178787

    T cell receptors for immunotherapy

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  21. US 12170134

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  22. US 12159700

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted
  23. US 12121541

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  24. US 12110334

    Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy

    The Regents of the University of California · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted